FindTrial
Sign In

Application of ERAS in Perioperative Period of Gynecology

Application of ERAS in Perioperative Period of Gynecology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021667
Enrollment
Unknown
Registered
2019-03-04
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological benign and malignant tumors

Interventions

Case series:ERAS relative measure

Sponsors

Shengjing Hospital, China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: All patients can be included in the ERAS process for treatment.

Exclusion criteria

Exclusion criteria: 1. If there are contraindications to the drugs that ERAS needs to use, it needs to be excluded in this project, but it does not affect the application of other project measures, such as preoperative anticoagulant drugs, postoperative pain allergy, or use of taboos. Should be ruled out; 2. After being informed, the patient explicitly stated that he did not use ERAS measures.

Design outcomes

Primary

MeasureTime frame
ERAS relative index;—

Countries

China

Contacts

Public ContactOuyang Ling

Shengjing Hospital, China Medical University

ouyang1964@163.com+86 18940251964

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026